Mode
Text Size
Log in / Sign up

Gray matter volume deviations in schizophrenia linked to symptom severity and cognitive functionCan brain volume patterns help us understand schizophrenia symptoms?

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Interpret GMV deviation associations in schizophrenia as exploratory neurobiological correlations, not causal biomarkers.

This multi-site observational cohort study examined the relationship between individual gray matter volume (GMV) deviations and schizophrenia diagnosis and symptoms. The study included 379 patients with schizophrenia spectrum disorders (SSDs) and 149 healthy controls, with normative models derived from a reference cohort of 7,957 healthy individuals. The primary outcome was the relationship between GMV deviations and schizophrenia diagnosis and symptoms.

Patients with SSDs showed significantly more negative average GMV deviations compared to healthy controls. Regional GMV deviations predicted diagnostic status with an area under the curve of 0.79. More negative GMV deviations were associated with higher symptom severity and lower cognitive functioning in SSD patients. The largest negative deviations were scattered across the brain, with the most pronounced alterations occurring in the salience network.

Safety and tolerability data were not reported in this neuroimaging study. Key limitations were not explicitly reported, but the authors note that the clinical relevance of normative modeling in SSDs 'remains controversial.' The study design was observational, showing associations rather than establishing causation. Practice relevance was not reported, and clinicians should interpret these findings as exploratory neurobiological correlations rather than clinically actionable biomarkers at this time.

What if the severity of schizophrenia symptoms could be linked to a specific, measurable pattern in the brain? A new observational study looked at brain scans from 379 people with schizophrenia spectrum disorders and compared them to healthy individuals. It found that people with these conditions tend to have less gray matter—the brain tissue packed with nerve cells—in a scattered pattern across the brain, with the biggest differences seen in areas related to the 'salience network,' which helps us focus on what's important.

The key finding is that the more a person's brain volume pattern deviated from the healthy average, the more severe their symptoms and the lower their cognitive function tended to be. The pattern of deviation could even distinguish between people with and without a diagnosis with a certain level of accuracy.

It's crucial to understand what this study does and does not show. This is an observational snapshot, meaning it found an association, not a cause. It doesn't tell us if these brain differences cause the symptoms or are a result of them. The researchers themselves note that using these 'normative models' in clinical practice for schizophrenia is still controversial. This is a step toward mapping the brain's landscape in these conditions, not a ready-made test or treatment.

What this means for you:
Brain volume patterns are linked to symptom severity in schizophrenia, but this doesn't show cause and effect.

Study Details

Study typeCohort
Sample sizen = 7,957
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Schizophrenia spectrum disorders (SSDs) are clinically and neurobiologically heterogeneous. Normative modeling addresses heterogeneity of structural brain alterations by focusing on individual-level deviations, but their clinical relevance in SSDs remains controversial. We mapped the relationship between individual gray matter volume (GMV) deviations and schizophrenia diagnosis and symptoms. Normative models of GMV were established using cross-sectional, T1-weighted magnetic resonance imaging data from a large, multi-site, healthy reference cohort (N = 7957). Deviations were derived for SSD patients (n = 379) and healthy controls (n =149). Patients showed a significantly more negative average deviation compared to controls and regional deviations predicted diagnostic status with adequate performance (AUC = 0.79). A more negative deviation was associated with higher symptom severity and lower cognitive functioning in SSD. Negative deviations were scattered across the brain, with the largest alterations in the salience network. Our findings strengthen the potential of normative modeling to disentangle the heterogeneous underpinnings of SSD and provide further evidence for individualized structural deviations, particularly in the salience network, as promising markers of illness severity in SSDs.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.